Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition

Patrick Brown, Soheil Meshinchi, Mark Levis, Todd A. Alonzo, Robert Gerbing, Beverly Lange, Robert Arceci, Donald Small

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Pediatric AML primary samples with FLT3/ITD mutations are preferentially killed by FLT3 inhibition'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds